# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-17-000031
Filing Date
2017-04-27
Accepted
2017-04-27 16:39:37
Documents
7
Effectiveness Date
2017-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A PRESENTATION 042717 | defa14apresentation042717.htm | DEFA14A | 17296
2 |  | caladriusarm2017fireside001.jpg | GRAPHIC | 72530
3 |  | caladriusarm2017fireside002.jpg | GRAPHIC | 239595
4 |  | caladriusarm2017fireside003.jpg | GRAPHIC | 127898
5 |  | caladriusarm2017fireside004.jpg | GRAPHIC | 111673
6 |  | caladriusarm2017fireside005.jpg | GRAPHIC | 141574
7 |  | caladriusarm2017fireside006.jpg | GRAPHIC | 66678
| Complete submission text file | 0000320017-17-000031.txt |  | 1066186

Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 17789693
SIC: 8090 Services-Misc Health & Allied Services, NEC